Translational PKPD modelling in schizophrenia. Linking receptor occupancy of antipsychotics to efficacy and safety
PhD ceremony: Mr. V. Pilla Reddy, 11.50 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertation: Translational PKPD modelling in schizophrenia. Linking receptor occupancy of antipsychotics to efficacy and safety
Promotor(s): prof. G.M.M. Groothuis, prof. M. Danhof
Faculty: Mathematics and Natural Sciences
The work of Venkatesh Pilla Reddy demonstrates how data from in vitro, preclinical and clinical studies can be combined to predict the optimal human dose for new antipsychotic drugs.
Schizophrenia is a severe psychiatric illness, which affects approximately 1% of the population and usually becomes manifest between the 15th and 30th year of life. The symptoms such as hallucinations and hearing voices can be reduced by antipsychotic drugs. These drugs are not always sufficiently effective against the various symptoms of schizophrenia. In the development of new medicines, it is difficult to predict whether they are effective, among others, because the efficacy is dependent on the amount of the drug that reaches the brain and binds to the dopamine receptors.
The research described in the thesis of Pilla Reddy aims to develop a mathematical model to predict the effectiveness of a new drug using in vitro data, data from animal experiments and PET scans in volunteers or patients, based on data for a number of existing drugs, accounting for the placebo effect. The model of Pilla Reddy shows that 50-70% of the receptors in the brain should be occupied by the drug to be sufficiently effective. If more than 80% of the receptors are occupied, the risk of side effects rises sharply. These results support the use of receptor occupancy as a biomarker in drug development.
The model was also applied to investigate whether the questionnaire (e.g., Positive and Negative Syndrome Scale), used by the psychiatrist to assess the efficacy of a drug, could be improved. The model demonstrates how data from in vitro, preclinical and clinical studies can be combined to understand drug effects in human. The model can be applied in drug development to characterize and predict the time courses of clinical effects.
Last modified: | 13 March 2020 01.02 a.m. |
More news
-
17 July 2024
Veni-grants for ten researchers in Groningen
The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.
-
15 July 2024
Funding for RUG researchers from National Growth Fund programme Circular Plastics NL
For research on making plastics circular, Professors Patrizio Raffa and Katja Loos together receive about 1.2 million euros from the National Growth Fund programme Circular Plastics NL.
-
09 July 2024
NWO Open Technology funding for improving quality 3D printing technology
Dr. Liangliang Cheng receives a NWO OPT grant of EUR 950,000 for research on safer application of metals in 3D printing technology.